U.S. Entertainment Stock News

NasdaqGS:LPLA
NasdaqGS:LPLACapital Markets

Reassessing LPL Financial Holdings (LPLA) Valuation After Recent Share Price Rebound

Why LPL Financial Holdings Is Drawing Fresh Attention LPL Financial Holdings (LPLA) is back on many watchlists after recent share price moves, including a gain of about 2.3% in the latest session. This has prompted a closer look at its fundamentals and valuation. See our latest analysis for LPL Financial Holdings. The recent 2.3% one day share price gain to about $301 sits against a weaker backdrop, with the share price down 16.7% year to date and total shareholder return down 21.5% over 12...
NYSE:BILL
NYSE:BILLSoftware

BILL Holdings Faces Activist Pressure As Buybacks And M&A Interest Grow

Activist investors, including Elliott Investment Management and Starboard Value, are reported to have built significant stakes in BILL Holdings (NYSE:BILL). These investors are pushing for a potential sale of the company, with BILL Holdings said to be reviewing strategic alternatives. Private equity firms and software focused buyers are reportedly showing fresh interest in acquiring the company following its valuation reset. BILL Holdings, which last closed at $39.96, is back in focus as...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Is Up 5.7% After AUVELITY Alzheimer’s Agitation Approval And Launch Push - Has The Bull Case Changed?

Axsome Therapeutics recently reported first-quarter 2026 results, with revenue of US$191.2 million and a net loss of US$64.54 million, and earlier in April received U.S. FDA approval for AUVELITY to treat agitation associated with dementia due to Alzheimer’s disease, backed by Phase 3 ADVANCE-1 and ACCORD-2 data. The AUVELITY label expansion creates a new opportunity in Alzheimer’s-related agitation, a highly prevalent, costly, and difficult-to-manage symptom, while Axsome prepares a June...
NYSE:HII
NYSE:HIIAerospace & Defense

A Look At Huntington Ingalls Industries (HII) Valuation After Strong Q1 Results And New Destroyer Delivery

Huntington Ingalls Industries (HII) is back in focus after first quarter revenue of US$3,099 million surpassed expectations, supported by shipbuilding, along with the delivery of the Flight III destroyer Ted Stevens (DDG 128). See our latest analysis for Huntington Ingalls Industries. At a share price of US$334.22, HII has seen its short term momentum cool, with a 30 day share price return down 15.27% and a 90 day return down 17.83%, even as the 1 year total shareholder return stands at...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

ExlService Names Singh To Lead EMEA And APAC As Shares Lag Targets

ExlService Holdings (NasdaqGS:EXLS) has appointed Bhupender Singh as President and Head of International Growth Markets. Singh will lead expansion across EMEA and APAC, focusing on data and AI-driven services. The move targets growth outside EXL's core US business and reflects an increased focus on international opportunities. For investors tracking NasdaqGS:EXLS, this leadership change comes after a tough share price period. The stock closed at $27.16, with the share price down 12.3% over...
NasdaqGM:MAZE
NasdaqGM:MAZEPharmaceuticals

Maze Therapeutics (MAZE) Q1 Loss Of US$24.2 Million Reinforces Bearish Earnings Narratives

Maze Therapeutics (MAZE) opened Q1 2026 with revenue of US$20 million and a basic EPS loss of US$0.45, alongside a net income loss of US$24.21 million, setting an earnings-season tone that is still firmly focused on managing losses. Over the past few quarters the company has gone from zero reported revenue in each quarter of 2025 to US$20 million in Q1 2026. Quarterly basic EPS has ranged from a loss of US$1.15 in Q1 2025 to a loss of US$0.45 in the latest period, putting the spotlight on how...
NasdaqCM:IRD
NasdaqCM:IRDBiotechs

Opus Genetics (IRD) Q1 Loss Of US$65.5 Million Intensifies Bearish Community Narratives

Opus Genetics (IRD) opened Q1 2026 with revenue of US$2.2 million and a basic EPS loss of US$0.75, putting a clear focus on how much cash the business is burning to support its growth plans. The company has reported quarterly revenue between US$2.9 million and US$4.4 million over the past five periods, while basic EPS losses have ranged from US$0.12 to US$1.16, giving investors a broad view of how the income statement changes as spending shifts. With profitability still some way off and...
NYSE:CPT
NYSE:CPTResidential REITs

Assessing Camden Property Trust (CPT) Valuation After Mixed Recent Share Price Performance

What recent performance tells you about Camden Property Trust (CPT) Camden Property Trust (CPT) has seen its stock move in a mixed pattern recently, with a gain over the past month alongside a decline over the past 3 months and over the past year. See our latest analysis for Camden Property Trust. At a share price of US$105.35, Camden’s recent 1 month share price return of 4.49% contrasts with a year to date share price decline of 4.38% and a 1 year total shareholder return decline of 5.25%...
NYSE:CMP
NYSE:CMPMetals and Mining

Compass Minerals (CMP) Is Up 14.2% After Returning To Profitability In Q2 2026 – What's Changed

Compass Minerals International, Inc. has reported past second-quarter 2026 results showing sales of US$453.2 million and net income of US$12.7 million, a shift from a net loss in the prior-year period, alongside stronger profitability for the first half of the fiscal year. This move from loss-making to earnings per share of US$0.30 in the quarter and US$0.73 over six months suggests meaningful progress in improving operational and financial performance. With this recent swing back to...
NYSE:HUBS
NYSE:HUBSSoftware

Assessing HubSpot (HUBS) Valuation After Strong Earnings Beat Guidance Hike And Growing AI Adoption

Why HubSpot’s latest earnings and AI push are in focus HubSpot (HUBS) is back on investors’ radar after first quarter 2026 earnings topped revenue expectations, full year revenue and margin guidance moved higher, and management spotlighted rapid uptake of AI powered customer support tools. See our latest analysis for HubSpot. Even with the earnings beat and stronger AI story, the share price is down 24% over the past week and 53% year to date, while the 1 year total shareholder return is down...
NYSE:REZI
NYSE:REZIBuilding

Resideo Sets Leadership For ADI Spin Off As Valuation Draws Attention

Resideo Technologies (NYSE:REZI) announced new leadership appointments for both Resideo and its planned spin off, ADI Global Distribution. The company outlined executive and board roles that will govern each business after the separation is complete. The spin off of ADI Global Distribution remains on track for completion between the third and fourth quarters of 2026. Resideo, which focuses on comfort, security and related products and services for homes and businesses, is preparing to...
NYSE:NEE
NYSE:NEEElectric Utilities

Record Q1 Profits And Renewables Backlog Surge Could Be A Game Changer For NextEra Energy (NEE)

In early May 2026, NextEra Energy reported a very large year-on-year profit increase in its Q1 results and a record quarter for its renewables and storage unit, which added 4 GW of projects to its backlog and drew positive attention from multiple Wall Street research firms. This combination of strong quarterly performance and a growing pipeline in renewables and storage underscores how central NextEra has become to supplying power for data centers and the broader shift toward...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday Expands AI Footprint From Enterprise Talent Suites To Solopreneurs

Workday (NasdaqGS:WDAY) has been named a Leader in the 2026 Gartner Magic Quadrant for Talent Acquisition Suites. The company introduced an AI-powered Solopreneurship Accelerator developed with leading AI partners. Workday integrated its Sana Self-Service Agent directly into Microsoft 365 Copilot, embedding its tools into everyday workflows. For investors tracking software-as-a-service platforms, these updates touch three different parts of Workday's business. Talent acquisition suites sit...
NasdaqGS:NCMI
NasdaqGS:NCMIMedia

National CineMedia (NCMI) Q1 Loss Reopens Debate Around Earnings Stability Narratives

Q1 2026 earnings snapshot National CineMedia (NCMI) has reported Q1 2026 revenue of US$34 million with a basic EPS loss of US$0.31, while trailing twelve month figures show revenue of US$242.3 million and a basic EPS loss of US$0.09. Over recent quarters, the company has seen quarterly revenue range from US$34 million to US$93.2 million, with basic EPS moving between a loss of US$0.32 and a profit of US$0.31. This sets up a mixed picture on earnings quality and operating leverage. For...
NYSE:FIGS
NYSE:FIGSLuxury

A Look At FIGS (FIGS) Valuation After A Volatile Stretch In Recent Share Performance

Stock performance snapshot and recent context FIGS (FIGS) has drawn investor attention after a mixed stretch, with the stock up about 6.1% in the latest session but down roughly 15.8% over the past week and month. See our latest analysis for FIGS. That sharp 1 day share price gain sits alongside a weaker recent patch, with the 7 day and 30 day share price returns both down around 16%, even as the 90 day share price return is up about 20% and the 1 year total shareholder return is very large...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

A Look At Lattice Semiconductor (LSCC) Valuation After Strong AI Driven First Quarter Results

Lattice Semiconductor (LSCC) just posted first quarter results that caught investor attention, with sales of US$170.9 million and net income of US$21.82 million, along with revenue guidance of US$175 million to US$195 million for the next quarter. See our latest analysis for Lattice Semiconductor. The recent earnings beat and AI focused demand story have come alongside strong momentum, with a 30 day share price return of 16.6% and year to date share price return of 59.76%, while the 1 year...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Legend Biotech (LEGN) Q1 Loss Persists And Tests Bullish Profitability Narratives

Legend Biotech (LEGN) has reported Q1 2026 revenue of US$305.1 million, with a basic EPS loss of US$0.29 and a net loss of US$54.3 million, setting the tone for a quarter where top line scale contrasts with continued spending. Over recent periods, revenue has moved from US$186.6 million in Q4 2024 to US$195.1 million in Q1 2025 and then to US$305.1 million in Q1 2026. Basic EPS has shifted from a profit of US$0.14 in Q4 2024 to losses of US$0.55 in Q1 2025 and US$0.29 in Q1 2026, leaving...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Assessing Illumina (ILMN) Valuation After Strong Recent Share Price Gains

Recent performance snapshot and context for Illumina (ILMN) Illumina (ILMN) has attracted fresh attention after recent share price moves, with the stock closing at US$145.00 and showing double digit gains over the past month and past 3 months. That shift comes against a backdrop of annual revenue of US$4.39b and net income of US$853.0m from its sequencing and array based genetic analysis business, which serves research, clinical, and commercial customers worldwide. See our latest analysis for...
NYSE:PATH
NYSE:PATHSoftware

UiPath For Coding Agents Prompts Fresh Look At UiPath (PATH) Valuation And Undervaluation Debate

Why UiPath’s new coding agent platform matters for PATH stock watchers UiPath (PATH) has drawn fresh attention after launching UiPath for Coding Agents, an industry first integration that makes popular AI coding agents deployable, orchestrated, and governed inside enterprise automation workflows. For investors, this product launch sits alongside UiPath’s broader agentic AI initiatives, including recent Automation Suite updates for regulated industries and government agencies. It also offers...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis

European Commission expands approval for Pfizer's HYMPAVZI (marstacimab) to include adolescents and adults with hemophilia A or B and inhibitors. Decision addresses a difficult to treat patient group with limited options due to resistance to traditional factor replacement therapies. Expanded authorization follows Phase 3 data indicating substantial reductions in annualized bleeding rates. Broader label increases HYMPAVZI’s eligible patient pool across Europe. For investors following Pfizer...
NYSE:INR
NYSE:INROil and Gas

Infinity Natural Resources (INR) Quarterly Loss Revives Concerns Over Earnings Quality Narratives

Infinity Natural Resources (INR) opened 2026 with Q1 revenue of US$154.9 million, a reported loss of US$1.9 million and basic EPS of US$0.11 loss, setting a mixed backdrop for investors reviewing the latest quarter. Over the past few reported periods the company has seen revenue move from US$69.1 million in Q4 2024 to US$85.2 million in Q1 2025, US$74.5 million in Q2 2025, US$79.7 million in Q3 2025 and US$117.1 million in Q4 2025, alongside EPS that has swung between a loss of US$2.27 and a...
NYSE:RJF
NYSE:RJFCapital Markets

A Look At Raymond James Financial (RJF) Valuation After Renewed Interest In Its Five Year Growth Record

Why Raymond James Financial’s recent track record is drawing fresh attention Recent coverage of Raymond James Financial (RJF) has focused on its five year record of compounded revenue and earnings growth, along with consistently high return on equity. Together, these factors appear to be rekindling interest in the stock. See our latest analysis for Raymond James Financial. At a share price of $153.96, Raymond James Financial’s 1 year total shareholder return of 2.51% sits against a softer...
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources Explores Onchain And Private Markets As Shares Outpace Targets

Franklin Resources (NYSE:BEN), through Franklin Templeton, has entered an onchain collaboration with Payward, the operator of Kraken, to develop tokenized, actively managed investments for institutional clients. The company has also launched Private Markets Model Portfolios with Corastone, aiming to give financial advisors more efficient access to diversified private market investments. These product moves come as Franklin Resources trades around $32.04, with the stock up 2.8% over the past...
NYSE:WEC
NYSE:WECIntegrated Utilities

Should WEC’s Earnings Beat, Bigger Dividend And US$37.5b Regulated Capex Plan Require Action From WEC (WEC) Investors?

WEC Energy Group recently reported past first-quarter 2026 results showing higher sales of US$3,434.2 million and net income of US$804.4 million, reaffirmed its 2026 earnings guidance of US$5.51–US$5.61 per share, and detailed a US$37.50 billion capital plan alongside a dividend increase. At the same time, the company confirmed plans to focus that record capital spending entirely on regulated assets, supporting its targeted 7–8% annual earnings-per-share growth ambition through 2030 while...